Amy Saur

563 total citations
5 papers, 62 citations indexed

About

Amy Saur is a scholar working on Molecular Biology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Amy Saur has authored 5 papers receiving a total of 62 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Immunology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Amy Saur's work include Lymphoma Diagnosis and Treatment (2 papers), Galectins and Cancer Biology (2 papers) and PI3K/AKT/mTOR signaling in cancer (1 paper). Amy Saur is often cited by papers focused on Lymphoma Diagnosis and Treatment (2 papers), Galectins and Cancer Biology (2 papers) and PI3K/AKT/mTOR signaling in cancer (1 paper). Amy Saur collaborates with scholars based in United States, Germany and South Korea. Amy Saur's co-authors include Amanda L. Christie, Ursula Zimber‐Strobl, Sarah Haebe, Robert Redd, James D. Griffin, Qingsong Liu, Alexandra Christodoulou, Jacob V. Layer, Caron A. Jacobson and Trevor Tivey and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Amy Saur

5 papers receiving 62 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy Saur United States	4	36	25	19	18	16	5	62
Emily Sheldon‐Waniga United States	6	32 0.9×	25 1.0×	7 0.4×	14 0.8×	44 2.8×	12	76
Małgorzata Oleś Germany	3	83 2.3×	11 0.4×	14 0.7×	14 0.8×	17 1.1×	9	100
Eirini S. Fasouli Greece	3	50 1.4×	15 0.6×	24 1.3×	6 0.3×	26 1.6×	4	89
Sasi Arunachalam United States	6	48 1.3×	13 0.5×	10 0.5×	9 0.5×	19 1.2×	11	93
Christopher Hickey United States	5	84 2.3×	9 0.4×	15 0.8×	10 0.6×	13 0.8×	10	111
Aron Skaftason Sweden	5	44 1.2×	9 0.4×	50 2.6×	10 0.6×	9 0.6×	7	84
Danielle L. Chappell United States	2	26 0.7×	18 0.7×	8 0.4×	8 0.4×	11 0.7×	4	52
Shaneice Mitchell United States	4	22 0.6×	17 0.7×	27 1.4×	12 0.7×	8 0.5×	8	47
Tony Andreas Müller Germany	4	26 0.7×	16 0.6×	29 1.5×	4 0.2×	13 0.8×	7	64
M. Fuertes Spain	4	45 1.3×	33 1.3×	52 2.7×	8 0.4×	12 0.8×	6	86

Countries citing papers authored by Amy Saur

Since Specialization

Citations

This map shows the geographic impact of Amy Saur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Saur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Saur more than expected).

Fields of papers citing papers by Amy Saur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Saur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Saur. The network helps show where Amy Saur may publish in the future.

Co-authorship network of co-authors of Amy Saur

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Saur. A scholar is included among the top collaborators of Amy Saur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Saur. Amy Saur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Jacobson, Caron A., Nadja Kopp, Jacob V. Layer, et al.. (2016). HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma. Blood. 128(21). 2517–2526. 30 indexed citations

2.

Klein, Sarah R., Kristen L. Jones, Amy Saur, et al.. (2015). Immune checkpoint blockade activates effective anti-tumor immunity in an orthotopic model of glioblastoma (VAC12P.1119). The Journal of Immunology. 194(1_Supplement). 213.10–213.10. 1 indexed citations

3.

Nonami, Atsushi, Martin Sattler, Ellen Weisberg, et al.. (2015). Identification of novel therapeutic targets in acute leukemias with NRAS mutations using a pharmacologic approach. Blood. 125(20). 3133–3143. 24 indexed citations

4.

Kopp, Nadja, Sarah Haebe, Diederik van Bodegom, et al.. (2014). Newer-Generation HSP90 Inhibitors Can Overcome Ibrutinib Resistance and Suppress Proliferation in Human Mantle Cell Lymphoma in Vitro and in Vivo. Blood. 124(21). 1686–1686. 4 indexed citations

5.

Crochiere, Marsha, Trinayan Kashyap, Boris Klebanov, et al.. (2014). Abstract 3810: Selinexor (KPT-330), a novel selective inhibitor of nuclear export (SINE), shows single agent efficacy against alveolar soft part sarcoma (ASPS) in vivo. Cancer Research. 74(19_Supplement). 3810–3810. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact